# Comparison of Standard Versus High Dose Urokinase for Dysfunctional Tunneled Dialysis Catheters in Haemodialysis Patients: A Randomized Controlled Trial

> **NCT06802679** · PHASE4 · COMPLETED · sponsor: **National Healthcare Group, Singapore** · enrollment: 44 (actual)

## Conditions studied

- Hemodialysis
- Thrombolytic Therapy
- Dialysis Access Dysfunction
- Randomised Controlled Trial
- End Stage Renal Disease (ESRD)

## Interventions

- **DRUG:** Urokinase
- **DRUG:** Urokinase

## Key facts

- **NCT ID:** NCT06802679
- **Lead sponsor:** National Healthcare Group, Singapore
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-01
- **Primary completion:** 2025-01-04
- **Final completion:** 2025-01-27
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2025-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06802679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06802679, "Comparison of Standard Versus High Dose Urokinase for Dysfunctional Tunneled Dialysis Catheters in Haemodialysis Patients: A Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06802679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*